Our Funds
Seed Fund I
Established a portfolio of early stage medical device companies that looked to solve real problems.
Seed Fund II
Created investment opportunities that allowed direct engagement into company operations.
Accellerator
Continued investing in technologies that improve outcomes & reduce healthcare system costs.
Opportunity
The Opportunity Fund leverages the foundation that the cultivate(MD) Seed and Accelerator Funds have built since 2017.
Representative Investments
Embody
Embody, Inc., is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address the unmet demands in soft tissue restoration and regeneration.
Imascap
Imascap develops software for preoperative planning of shoulder replacement surgery.
Shoulder Innovations
Shoulder Innovations’ InSet™ Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant.
News and Updates
cultivate (MD) Capital Funds Portfolio Company Virtual Incision Submits FDA De Novo Request for Market Authorization of MIRA
Grand Rapids, Mich., May 22, 2023— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today
HAPPE Spine Announces FDA Clearance for the INTEGRATE-C™ Interbody Fusion System
Grand Rapids, Mich., May 8, 2023 — HAPPE Spine, a medical device company focused on bringing innovative materials to orthopaedic implants, announces that the company’s
Shoulder Innovations Announces Additional Patent for Inset™ Reverse Shoulder System
Grand Rapids, Mich., April 27th, 2023 Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market, announced today that
An Interview with Julius Heil
On March 1, 2023 cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced one of their portfolio companies,
SentiAR Announces Close of $8.5 million Series B Financing
Expand Partnerships and Clinical Deployments St. Louis, Missouri, April 11th, 2023 — SentiAR, Inc. a St. Louis, Missouri based pioneer in using Augmented Reality (AR)
Interview with Andrew Iott, the New President and CEO of HAPPE Spine
We recently had the opportunity to meet with Andrew Iott, HAPPE Spine’s new President and CEO. HAPPE Spine announced in December of 2022 that Andrew